John Tu-backed Fluxergy traveling to Harvard for accelerator

Irvine diagnostics company Fluxergy Inc., which developed a one-hour COVID-19 test, will be an inaugural member of the Wyss Diagnostics Accelerator's Industrial Participant Program at Harvard University.

During its time in the program, the 10year-old company plans to collaborate with distinguished clinicians, researchers, engineers, and other entities on diagnostic solutions in areas of unmet clinical needs, the company said.

“After an initial meeting with the inaugural partners, I’m ecstatic,” Fluxergy co-founder and CEO Tej Patel said in a statement. “We have a room full of scientific and commercial heavy weights that can enact change especially for matching unmet needs with ideal technologies.”

Fluxergy’s goal is to manufacture its multimodal testing system, which is designed to conduct PCR, immunoassays, chemistry, and cell counting all on one, the company said. It can be used in infectious disease, chronic blood disorders, cancer, sepsis, and chronic kidney disease applications.

The company is backed by Kingston Technology co-founder John Tu.

“It’s very unique to be in a consortium of seasoned and passionate people with such diverse backgrounds: applications in human health, veterinary medicine, and food safety, presence in each of the global markets, and platform technologies that cover telehealth, diagnostics, drug discovery, and digital health,” Patel added.